GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $646,147,000 | -2.3% | 14,843,717 | -2.3% | 0.08% | +22.4% |
| Q1 2022 | $661,562,000 | -0.8% | 15,187,378 | +0.4% | 0.07% | +11.7% |
| Q4 2021 | $666,801,000 | +18.1% | 15,120,199 | +2.3% | 0.06% | +13.2% |
| Q3 2021 | $564,671,000 | -3.3% | 14,778,118 | +0.7% | 0.05% | -1.9% |
| Q2 2021 | $584,104,000 | +5.3% | 14,668,615 | -5.6% | 0.05% | -3.6% |
| Q1 2021 | $554,739,000 | -8.9% | 15,543,281 | -6.1% | 0.06% | -11.1% |
| Q4 2020 | $608,900,000 | -8.5% | 16,552,117 | -6.4% | 0.06% | -18.2% |
| Q3 2020 | $665,786,000 | -7.4% | 17,688,257 | +0.4% | 0.08% | -14.4% |
| Q2 2020 | $718,860,000 | +10.5% | 17,623,433 | +2.7% | 0.09% | -12.6% |
| Q1 2020 | $650,406,000 | -9.2% | 17,165,627 | +12.6% | 0.10% | +10.8% |
| Q4 2019 | $716,572,000 | +10.1% | 15,249,459 | +0.0% | 0.09% | +1.1% |
| Q3 2019 | $650,605,000 | +7.3% | 15,243,794 | +0.6% | 0.09% | +8.2% |
| Q2 2019 | $606,489,000 | -13.9% | 15,154,650 | -10.1% | 0.08% | -18.3% |
| Q1 2019 | $704,539,000 | +1.9% | 16,859,039 | -6.8% | 0.10% | -11.1% |
| Q4 2018 | $691,261,000 | +5.2% | 18,091,096 | +10.6% | 0.12% | +21.9% |
| Q3 2018 | $657,095,000 | -2.3% | 16,357,851 | -1.9% | 0.10% | -6.8% |
| Q2 2018 | $672,243,000 | +4.5% | 16,676,833 | +1.3% | 0.10% | +1.0% |
| Q1 2018 | $643,143,000 | +9.4% | 16,461,309 | -0.7% | 0.10% | +7.4% |
| Q4 2017 | $587,750,000 | -13.4% | 16,570,353 | -0.8% | 0.10% | -18.1% |
| Q3 2017 | $678,355,000 | +17.0% | 16,708,263 | +24.2% | 0.12% | +11.5% |
| Q2 2017 | $580,002,000 | +28.8% | 13,450,891 | +26.0% | 0.10% | +23.8% |
| Q1 2017 | $450,208,000 | +12.5% | 10,678,557 | +2.7% | 0.08% | +6.3% |
| Q4 2016 | $400,228,000 | +14.7% | 10,392,844 | +28.5% | 0.08% | +12.9% |
| Q3 2016 | $348,815,000 | +3.8% | 8,087,528 | +4.3% | 0.07% | -1.4% |
| Q2 2016 | $336,131,000 | +19.4% | 7,755,672 | +11.7% | 0.07% | +18.3% |
| Q1 2016 | $281,614,000 | -15.4% | 6,944,865 | -15.8% | 0.06% | -14.3% |
| Q4 2015 | $332,876,000 | +7.3% | 8,249,709 | +2.3% | 0.07% | +1.4% |
| Q3 2015 | $310,120,000 | +19.6% | 8,065,535 | +29.5% | 0.07% | +30.2% |
| Q2 2015 | $259,308,000 | -36.0% | 6,225,873 | -29.1% | 0.05% | -36.9% |
| Q1 2015 | $405,417,000 | +13.2% | 8,784,758 | +4.9% | 0.08% | +10.5% |
| Q4 2014 | $358,083,000 | -6.5% | 8,378,163 | +0.6% | 0.08% | -9.5% |
| Q3 2014 | $382,824,000 | -20.8% | 8,327,693 | -7.9% | 0.08% | -19.2% |
| Q2 2014 | $483,450,000 | +0.6% | 9,039,831 | +0.5% | 0.10% | -3.7% |
| Q1 2014 | $480,749,000 | -45.5% | 8,997,728 | -45.5% | 0.11% | +6.9% |
| Q4 2013 | $881,682,000 | +153.4% | 16,513,988 | +138.1% | 0.10% | +16.1% |
| Q3 2013 | $347,919,000 | -53.6% | 6,934,811 | -53.8% | 0.09% | -13.0% |
| Q2 2013 | $750,278,000 | – | 15,014,552 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |